* Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune ...
* Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses * Phase 1/...
* Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completio...
* Company holds a dedicated meeting with Gates Foundation executives during Bill Gates' visit to ...
* Company aims for technology advancement and platform expansion with Korea's first influenza vac...
* No patent infringement found in exports of individual conjugate bulk substances and research-us...
* Company aims to develop a bird flu vaccine with rapid mass production and variant responsivenes...
* SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials inAustralia and N...
* SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials inAustralia i...
* This approval paves the way for exports to the world's fourth most populous country. * SK bio...
* This approval paves the way for exports to the world's fourth most populous country. * SK bio...
* SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation...
* SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a centur...
* Company exported 440,000 doses to Thailand, marking its entry into the Southeast Asian market a...
* Jaeyong Ahn, CEO of SK bioscience, presents the 'Glocalization' project to secure the global va...
* The additional investment for the 'R&PD Center' was confirmed by the board of directors committ...
* SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the R...
* Two biopharmaceutical experts join SK bioscience to strengthen the future strategies * With r...
* The world-second developed shingles vaccine 'SKYZoster™' is approved by the National Pharmaceut...
* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience...
